» Articles » PMID: 1387150

Schistosoma Mansoni Eggs Induce Antigen-responsive CD44-hi T Helper 2 Cells and IL-4-secreting CD44-lo Cells. Potential for T Helper 2 Subset Differentiation is Evident at the Precursor Level

Overview
Journal J Immunol
Date 1992 Sep 1
PMID 1387150
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Schistosoma mansoni eggs are potent inducers of biased Th2-like immune responses. Using a model system where mice are immunized with isolated schistosome eggs, we demonstrate that CD44 expression, up-regulation of which has been linked to Th cell development, is increased on Th2 cells. We also investigate the functional properties of CD44-lo Th cells recovered from the overtly Th2 environment constituted by lymph nodes draining sites of egg deposition. Production of high levels of IL-4, IL-5, and IL-10 by Th cells responding to egg Ag is shown to be the property of a subpopulation expressing CD44-hi. This population of Th cells cosegregates with a blasting subpopulation expressing more IL-4R (but similar amounts of IL-2R) than Th cells from normal mice. These results indicate that mature Th2 cells responding to schistosome eggs are CD44-hi and suggest that they use IL-4 as a growth factor. In contrast, CD44-lo cells sorted from lymph node populations responding to eggs are able to produce small amounts of IL-4 and IL-2, but no IL-5 or IL-10. This is surprising, because low expression of CD44 is considered a characteristic of Th cell naivite and concomitant ability to produce only IL-2. Thus, in lymph nodes responding to schistosome eggs, potential for Th2 subset differentiation is evident within the CD44-lo precursor Th subpopulation.

Citing Articles

Trickle infection with results in decreased worm burdens but increased intestinal inflammation and scarring.

Ariyaratne A, Kim S, Pollo S, Perera S, Liu H, Nguyen W Front Immunol. 2022; 13:1020056.

PMID: 36569914 PMC: 9773095. DOI: 10.3389/fimmu.2022.1020056.


Changes in the lipid profile of hamster liver after Schistosoma mansoni infection, characterized by mass spectrometry imaging and LC-MS/MS analysis.

Wiedemann K, Peter Ventura A, Gerbig S, Roderfeld M, Quack T, Grevelding C Anal Bioanal Chem. 2022; 414(12):3653-3665.

PMID: 35320368 PMC: 9035427. DOI: 10.1007/s00216-022-04006-6.


Schistosome immunomodulators.

Acharya S, Dadara A, Skelly P PLoS Pathog. 2021; 17(12):e1010064.

PMID: 34969052 PMC: 8718004. DOI: 10.1371/journal.ppat.1010064.


Comparative Transcriptomics of IBD Patients Indicates Induction of Type 2 Immunity Irrespective of the Disease Ideotype.

Gonzalez Acera M, Patankar J, Diemand L, Siegmund B, Neurath M, Wirtz S Front Med (Lausanne). 2021; 8:664045.

PMID: 34136502 PMC: 8200538. DOI: 10.3389/fmed.2021.664045.


Immune Evasion Strategies of Schistosomes.

Hambrook J, Hanington P Front Immunol. 2021; 11:624178.

PMID: 33613562 PMC: 7889519. DOI: 10.3389/fimmu.2020.624178.